Markets
Tendies
@tendies
Bought TNXP
Shares
down -5.49%
At 0.18, Now 0.17
I've been looking into Tonix Pharmaceuticals, and with their potential breakthrough drug awaiting FDA approval likely in 2025, I believe this stock is...
Read
More
Thesis
I've been looking into Tonix Pharmaceuticals, and with their potential breakthrough drug awaiting FDA approval likely in 2025, I believe this stock is a great opportunity. The promising test results and upcoming investor summit could lead to significant growth in the coming months.
Go back
Tendies
@tendies
Bought TNXP
Shares
down -2.17%
At 0.14, Exited 0.14
I just bought over 12,000 shares of TNXP because I'm seeing potential for a breakout tomorrow morning according to the graphs on Robinhood. Despite so...
Read
More
Thesis
I just bought over 12,000 shares of TNXP because I'm seeing potential for a breakout tomorrow morning according to the graphs on Robinhood. Despite some skepticism from others regarding pump and dump actions, I’m feeling confident about this move.
Go back
Tendies
@tendies
Bought TNXP
Shares
down -12.94%
At 0.16, Exited 0.14
With Tonix's recent $34 million contract from the DTRA, I see a strong validation of their antiviral programs and potential for substantial growth. Th...
Read
More
Thesis
With Tonix's recent $34 million contract from the DTRA, I see a strong validation of their antiviral programs and potential for substantial growth. The optimism around their ongoing research gives me confidence to hold my shares and perhaps even buy more in anticipation of future price increases.
Go back
Tendies
@tendies
Bought TNXP
Shares
up 4.94%
At 0.16, Now 0.17
I just bought into TNXP because there's a strong sentiment around a potential government contract and an anticipated FDA approval for their new fibrom...
Read
More
Thesis
I just bought into TNXP because there's a strong sentiment around a potential government contract and an anticipated FDA approval for their new fibromyalgia medication in Q1 2025. The product could significantly impact the market as it's the first in 15 years, making this a solid long-term investment.
Go back
Tendies
@tendies
Bought TNXP
Shares
down -0.5%
At 0.18, Exited 0.18
I just came across some exciting news about TNXP receiving $34 million from DTRA for developing antiviral agents. This substantial funding can lead to...
Read
More
Thesis
I just came across some exciting news about TNXP receiving $34 million from DTRA for developing antiviral agents. This substantial funding can lead to significant advancements for the company, making it an attractive long-term investment opportunity.
Go back
Tendies
@tendies
Bought TNXP
Shares
down -32.94%
At 0.34, Exited 0.23
I feel like TNXP is going to be next after profiting well on APDN, both being mpox stocks. This makes TNXP a potential swing play based on its relativ...
Read
More
Thesis
I feel like TNXP is going to be next after profiting well on APDN, both being mpox stocks. This makes TNXP a potential swing play based on its relative performance and market behavior expectations.
Go back
Scalp
@scalpgan...
Bought TNXP
Shares
up 6.38%
At 0.34, Exited 0.36
TNXP is poised to blow over $0.40 as it has just released the monkeypox vaccine. I expect it to hit $0.45 by the end of the day. Don't miss out on thi...
Read
More
Thesis
TNXP is poised to blow over $0.40 as it has just released the monkeypox vaccine. I expect it to hit $0.45 by the end of the day. Don't miss out on this short-term opportunity.
Go back
Tendies
@tendies
Bought TNXP
Shares
down -50.83%
At 0.34, Exited 0.17
With TNXP's upcoming NDA submission for TNX-102 by EOY 2024 and a high Fast Track approval rate of 75%, I believe there's a significant upside potenti...
Read
More
Thesis
With TNXP's upcoming NDA submission for TNX-102 by EOY 2024 and a high Fast Track approval rate of 75%, I believe there's a significant upside potential. TNXP is trading at a deep discount, and if TNX-102 gets approved, the stock could see a monumental increase due to the drug's revenue potential.
Go back
